Pensioenfonds Rail & OV Cuts Stock Holdings in CVS Health Co. (NYSE:CVS)

Pensioenfonds Rail & OV reduced its stake in shares of CVS Health Co. (NYSE:CVS - Free Report) by 99.3% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 4,672 shares of the pharmacy operator's stock after selling 638,385 shares during the quarter. Pensioenfonds Rail & OV's holdings in CVS Health were worth $373,000 at the end of the most recent quarter.

A number of other hedge funds also recently added to or reduced their stakes in the stock. SOA Wealth Advisors LLC. grew its position in CVS Health by 4.9% in the 4th quarter. SOA Wealth Advisors LLC. now owns 2,859 shares of the pharmacy operator's stock valued at $226,000 after buying an additional 133 shares in the last quarter. Apella Capital LLC boosted its position in shares of CVS Health by 4.2% during the 4th quarter. Apella Capital LLC now owns 3,378 shares of the pharmacy operator's stock valued at $272,000 after purchasing an additional 136 shares in the last quarter. Prairie Sky Financial Group LLC lifted its stake in CVS Health by 4.1% during the fourth quarter. Prairie Sky Financial Group LLC now owns 3,612 shares of the pharmacy operator's stock valued at $285,000 after purchasing an additional 141 shares during the last quarter. WealthShield Partners LLC boosted its holdings in shares of CVS Health by 3.2% in the fourth quarter. WealthShield Partners LLC now owns 4,498 shares of the pharmacy operator's stock worth $355,000 after buying an additional 141 shares during the period. Finally, Sugarloaf Wealth Management LLC boosted its stake in CVS Health by 9.5% in the 4th quarter. Sugarloaf Wealth Management LLC now owns 1,639 shares of the pharmacy operator's stock worth $129,000 after purchasing an additional 142 shares during the period. 80.66% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several brokerages have recently commented on CVS. The Goldman Sachs Group decreased their target price on CVS Health from $85.00 to $74.00 and set a "buy" rating for the company in a research report on Thursday, May 2nd. JPMorgan Chase & Co. cut their price objective on CVS Health from $101.00 to $86.00 and set an "overweight" rating for the company in a report on Thursday, May 30th. Wells Fargo & Company cut their price target on CVS Health from $76.00 to $60.00 and set an "equal weight" rating for the company in a research note on Tuesday, May 7th. TD Cowen downgraded shares of CVS Health from a "buy" rating to a "hold" rating and cut their price target for the company from $99.00 to $59.00 in a report on Tuesday, May 7th. Finally, Argus reduced their price objective on shares of CVS Health from $100.00 to $80.00 and set a "buy" rating for the company in a research note on Wednesday, May 8th. Eleven equities research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company's stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $75.05.

Insider Activity

In other CVS Health news, Director Edward J. Ludwig purchased 1,000 shares of the company's stock in a transaction that occurred on Thursday, May 2nd. The shares were acquired at an average price of $53.88 per share, with a total value of $53,880.00. Following the transaction, the director now owns 21,630 shares in the company, valued at $1,165,424.40. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 0.24% of the company's stock.

CVS Health Price Performance

Shares of CVS stock traded up $0.19 on Wednesday, hitting $60.63. 8,197,643 shares of the company's stock were exchanged, compared to its average volume of 12,049,123. The company has a 50 day moving average of $60.16 and a 200 day moving average of $70.45. The stock has a market cap of $76.11 billion, a P/E ratio of 10.66, a price-to-earnings-growth ratio of 0.58 and a beta of 0.53. CVS Health Co. has a 12 month low of $52.77 and a 12 month high of $83.25. The company has a debt-to-equity ratio of 0.78, a current ratio of 0.81 and a quick ratio of 0.61.

CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings results on Wednesday, May 1st. The pharmacy operator reported $1.31 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.69 by ($0.38). CVS Health had a return on equity of 13.53% and a net margin of 2.03%. The business had revenue of $88.44 billion for the quarter, compared to the consensus estimate of $89.33 billion. During the same quarter in the previous year, the company posted $2.20 earnings per share. CVS Health's quarterly revenue was up 3.7% on a year-over-year basis. On average, equities research analysts predict that CVS Health Co. will post 7.02 EPS for the current year.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.